Soluble P-selectin moderates complement dependent injury

Shock

Volumn 14, Issue 6, 2000, Pages 610-615

  Woodcock, Sean A ^a   Kyriakides, Constantinos ^a   Wang, Yong ^a   Austen Jr , William G ^a   Moore Jr , Francis D ^a   Valeri, Robert ^b   Hartwell, Denisa ^c   Hechtman, Herbert B ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b CENTER FOR BLOOD RESEARCH   (United States)

^c BOSTON UNIVERSITY   (United States)

Author keywords

Ischemia reperfusion complement soluble p selectin platelets short consensus repeats

Indexed keywords

COMPLEMENT; PADGEM PROTEIN;

ANIMAL; ARTICLE; BLOOD; COMPLEMENT CLASSICAL PATHWAY; GENETICS; HINDLIMB; IMMUNOLOGY; INJURY; INTESTINE; MALE; METABOLISM; MOUSE; MOUSE MUTANT; REPERFUSION INJURY; SOLUBILITY; THROMBOCYTE; VASCULARIZATION;

ANIMALS; BLOOD PLATELETS; COMPLEMENT PATHWAY, CLASSICAL; COMPLEMENT SYSTEM PROTEINS; HINDLIMB; INTESTINES; MALE; MICE; MICE, KNOCKOUT; P-SELECTIN; REPERFUSION INJURY; SOLUBILITY;

EID: 0034543105     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/00024382-200014060-00007     Document Type: Article

References (33)

1. Berman CL, Yeo EL, Wencel-Drake JD, Furie BC, Ginsberg M, Furie B: A platelet alpha-granule membrane protein that is associated with the plasma membrane after activation: characterization and subcellular localization of platelet activation-dependent granule-external membrane protein. J Clin Investig 78:130-137, 1986.
2. Stenberg PE, McEver RP, Shumen MA, Jacques YV, Bainton DF: A platelet alpha-granule membrane protein (GMP 140) is expressed on the plasma membrane after activation. J Cell Biol 101:880-886, 1985.
3. Bonfanti R, Furie BC, Furie B, Wagner DD: PADGEM (GMP-140) is a component of Weibel-Palade bodies of human endothelial cells. Blood 73:1109-1112, 1989.
4. McEver RP, Beckstead JH, Moore KL, Marshall-Carlson L, Bainton DF: GMP-140, a platelet alpha-granule membrane protein, is also synthesized by vascular endothelial cells and is located in Weibel-Palade bodies. J Clin Investig 84:92-99, 1989.
5. Carlos TM, Harlan JM: Leukocyte-endothelial adhesion molecules. Blood 84(7): 2068-2101, 1994.
6. Bevilaccqua MP, Nelson RM: Selectins. J Clin Investig 91:379-387, 1993.
7. Moore KL, Eaton SF, Lyons DE, Lichenstein HS. Cummings RD, McEver R: The P-selectin glycoprotein ligand from human neutrophils displays sialylated, fucosylated, O-linked poly-N-acetyllactosamine. J Biol Chem 269(37):23318-23327, 1994.
8. Ushiyama S, Laue TM, Moore KL, Erickson HP, McEver RP: Structural and functional characterization of monomeric soluble P-selectin and comparison with membrane P-selectin. J Biol Chem 269(20):15229-15237, 1993.
9. Kansas GS, Spertini O, Stoolman LM, Tedder TF: Molecular mapping of functional domains of the leukocyte receptor for endothelium LAM-1. J Cell Biol 114:351-358, 1991.
10. Katayama M, Handa M, Araki Y, Ambo H, Kawai Y, Watanabe K, Ikeda Y: Soluble P-selectin is present in normal circulation and its plasma level is elevated in patients with thrombotic thrombocytopenia purpura and haemolytic uremic syndrome. Br J Haematol 84:702-710, 1993.
11. Berger G, Hartwell DW, Wagner DD: P-selectin and Platelet clearance. Blood 92:4446-4452, 1998.
12. Ishiwata N, Takios K, Katayama M, Watanabe K, Titani K, Ikeda Y, Handa M: Alternatively spliced isoform of P-selectin is present in in vivo as a soluble molecule. J Biol Chem 269:23708-23715, 1994.
13. Takeda I, Kaise S, Nishimaki T, Kasukawa R: Soluble P-selectin in the plasma of patients with connective tissue diseases. Intl Arch Allergy Immunol 105:128-134, 1994.
14. Chong BH, Murray B, Berndt MC, Dunlop LC, Brighton T, Chesterman CN: Plasma P-selectin is increased in thrombotic consumptive platelet disorders. Blood 83:1535-1541, 1994.
15. Tu L, Chen A, Delahunty MD, Moore KL, Watson SR, McEver RP, Tedder TF: L-selectin binds to P-selectin glycoprotein ligand-1 on leukocytes: interactions between the lectin, epidermal growth factor, and consensus repeat domains of the selectins determine ligand binding specificity. J Immunol 157:3995-4004, 1996.
16. Patel KD, Nollert MU, McEver RP: P-selectin must extend a sufficient length from the plasma membrane to mediate rolling of neutrophils. J Cell Biol 131:1893-1902, 1995.
17. Buerke M, Prufer D, Dahm M, Oelert H, Meyer J, Darius H: Blocking of classical complement pathway inhibits endothelial adhesion molecule expression and preserves ischemic myocardium from reperfusion injury. J Pharmacol Exp Ther 286:429-438, 1998.
18. Williams JP, Pechet TTV, Kobzik L, Hechtman HB, Carroll MC: Intestinal ischemia is IgM and complement mediated. J Appl Physiol 86:938-942, 1999.
19. Austen WG Jr, Woodcock SAA, Prodeus A, Reid R, Pechet T, Moore FD Jr, Kobzik L, Hechtman H, Carroll MC: Self-reactive immunoglobulin M from peritoneal B cells mediates murine intestinal ischemia-reperfusion injury. Surgical Forum XLIX:341-342, 1998.
20. Peerschke EI, Ghebrehiwet B: Clq augments platelet activation in response to aggregated Ig. J Immunol 159:5594-5598, 1997.
21. Klerx JP, Beukelman CJ, Van Dijk H, Willers JMN: Microassay for colorimetric estimation of complement activity in guinea pig, human, and mouse serum. J Immunol Methods 63:215-220, 1983.
22. Dewaal RMW, Schrijver G, Bogman MJJT, Assmann KJM, Koene RAP: An improved sensitive and simple microassay of mouse complement. J Immunol Methods 108:213-221, 1988.
23. Kyriakides C, Woodcock S, Austen WG, Wang Y, Kobzik L, Moore FD, Valeri CR, Shepro D, Hechtman HB: Soluble P-selectin moderates skeletal muscle reperfusion injury. Am J Physiol (in press), 2000.
24. Tanaka S, Suzuki T, Nishioka K: Assay of classical and alternative pathway activities of murine complement using antibody-sensitized rabbit erythrocytes. J Immunol Methods 86:161-170, 1986.
25. Garnette CSC, Rohrer LA, Valeri CR, Barnard MR, Frelinger AL, Claytor RB, Krueger LA, Hechtman HB, Furman MI, Michaelson AD: Leukocyte cathespin G proteolses platelet surface P-selectin and disaggregates leukocyte-platelet complexes: mechanism for the loss of surface P-selectin from circulating degranulated platelets. American Heart Association, 72 Scientific Sessions. Atlanta Nov 7-10, 1999.
26. Michelson AD, Barnard MR, Hechtman HB, MacGregor H, Connolly RJ, Loscalzo J, Valeri CR: In vivo tracking of platelets: circulating degranulated platelets rapidly lose surface P-selectin but continue to circulate and function. Proc Natl Acad Sci USA 93:11877-11882, 1996.
27. Simpson R, Alon R, Kobzik L, Valeri C.R, Shepro D, Hechtman HB.: Neutrophil and non-neutrophil mediated injury in intestinal ischemia reperfusion injury. Ann Surg 218:444-454, 1993.
28. Weiser MR, Williams JP, Moore FD, Kobzik L, Hechtman HB, Carroll MC: Reperfusion injury of ischemic skeletal muscle is mediated by natural antibody and complement. J Exp Med 183:2343-2348, 1996.
29. Mehta P, Patel KD, Laue TM, Erickson HP, McEver RP: Soluble monomeric P-selectin containing only the lectin and epidermal growth factor domains binds to P-selectin glycoprotein ligand-I on leukocytes. Blood 90: 2381-2389, 1997.
30. Kansas GS, Saunders KB, Ley K, Zakrzewicz A, Gibson RM, Furie BC, Furie B, Tedder TF: A role for the epidermal growth factor-like domain of P-selectin in ligand recognition and cell adhesion. J Cell Biol 124:609-618, 1994.
31. Ruchaud-Sparagano MH, Malaud E, Gayet O, Chignier E, Buckland R, McGgregor JL: Mapping the epitope of a functional P-selectin monoclonal antibody (LYP20) to a short complement-like repeat (SCR 4) domain: use of human-mouse chimera and homologue-replacement mutagenesis. Biochem J 332:309-314, 1998.
32. Hill J, Lindsay TF, Oritz F, Yeh CG, Hechtman HB, Moore FD Jr: Soluble complement receptor Type 1 ameliorates the local and remote organ injury after intestinal ischemia-reperfusion injury in the rat. J Immunol 149: 1723-1728, 1992.
33. Setiadi H, Disdier M, Green SA, Canfield WM, McEver RP: Residues throughout the cytoplasmic domain affect the internalization efficiency of P-selectin. J Biol Chem 270:26818-26826, 1995.